SPY302.97-0.56 -0.18%
DIA254.35-1.42 -0.56%
IXIC9,368.99-43.37 -0.46%

Adaptive Biotechnologies Q1 EPS $(0.250) Misses $(0.210) Estimate, Sales $20.910M Miss $22.660M Estimate

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.250) per share which missed the analyst consensus estimate of $(0.210) by 19.05 percent. This is a 82.76 percent increase over losses of $(1.450)

Benzinga · 05/12/2020 20:06

Adaptive Biotechnologies (NASDAQ:ADPT) reported quarterly losses of $(0.250) per share which missed the analyst consensus estimate of $(0.210) by 19.05 percent. This is a 82.76 percent increase over losses of $(1.450) per share from the same period last year. The company reported quarterly sales of $20.910 million which missed the analyst consensus estimate of $22.660 million by 7.72 percent. This is a 65.09 percent increase over sales of $12.666 million the same period last year.